FSD Pharma Inc., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. FSD Pharma Inc. is headquartered in Toronto, Canada.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-07-18 |
2024-06 |
-0.06 |
N/A |
N/A |
N/A |
2024-05-14 |
2024-03 |
-0.05 |
-0.05 |
N/A |
N/A |
2024-03-28 |
2023-12 |
0 |
N/A |
N/A |
N/A |
2024-03-28 |
2023-12 |
0 |
-0.04 |
N/A |
N/A |
2023-11-14 |
2023-09 |
0 |
N/A |
N/A |
N/A |
2023-11-14 |
2023-09 |
0 |
-0.03 |
N/A |
N/A |
Date |
Name |
Relation |
Quantity |
Description |
2022-03-28 |
Bokhari (Raza) |
10% Security Holder of Issuer |
5.53K |
Redemption, retraction, cancelation, repurchase |
2022-09-26 |
Carroll (Donal) |
Director of Issuer |
263.44K |
Acquisition or disposition in the public market |
2022-06-09 |
Coyle (Nathan Patrick) |
Senior Officer of Issuer |
2.50K |
Acquisition or disposition in the public market |
2022-04-24 |
Durkacz (Anthony John) |
10% Security Holder of Issuer |
273.60K |
Acquisition or disposition in the public market |
2022-09-25 |
FSD Pharma, Inc. |
Issuer |
219.40K |
Redemption, retraction, cancelation, repurchase |
2021-12-06 |
Kotra (Lakshmi) |
Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) |
298.00K |
Acquisition or disposition in the public market |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
AdvisorShares Investments, LLC |
249.31K |
286.70K |
0.63% |
2023-06-29 |
Renaissance Technologies, LLC |
102.60K |
117.99K |
0.26% |
2023-06-29 |
Susquehanna International Group, LLP |
57.47K |
66.08K |
0.15% |
2023-06-29 |
Janney Montgomery Scott LLC |
15.00K |
17.25K |
0.04% |
2023-06-29 |
Two Sigma Securities, LLC |
10.16K |
11.69K |
0.03% |
2023-06-29 |
Royal Bank of Canada |
2.18K |
2.50K |
0.01% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-09-29 |
AdvisorShares Trust-AdvisorShares Psychedelics ETF |
235.64K |
285.26K |
0.60% |
Split |
Date |
1 : 201 |
2019-10-16 |